9-134911267-C-T
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_002003.5(FCN1):c.599G>A(p.Gly200Glu) variant causes a missense, splice region change. The variant allele was found at a frequency of 0.0000372 in 1,613,870 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 13/23 in silico tools predict a benign outcome for this variant. 3/3 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_002003.5 missense, splice_region
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
FCN1 | NM_002003.5 | c.599G>A | p.Gly200Glu | missense_variant, splice_region_variant | 8/9 | ENST00000371806.4 | NP_001994.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
FCN1 | ENST00000371806.4 | c.599G>A | p.Gly200Glu | missense_variant, splice_region_variant | 8/9 | 1 | NM_002003.5 | ENSP00000360871 | P1 |
Frequencies
GnomAD3 genomes AF: 0.000105 AC: 16AN: 152142Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000438 AC: 11AN: 251388Hom.: 0 AF XY: 0.0000368 AC XY: 5AN XY: 135866
GnomAD4 exome AF: 0.0000301 AC: 44AN: 1461728Hom.: 1 Cov.: 31 AF XY: 0.0000289 AC XY: 21AN XY: 727158
GnomAD4 genome AF: 0.000105 AC: 16AN: 152142Hom.: 0 Cov.: 32 AF XY: 0.0000942 AC XY: 7AN XY: 74316
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Aug 12, 2021 | The c.599G>A (p.G200E) alteration is located in exon 8 (coding exon 8) of the FCN1 gene. This alteration results from a G to A substitution at nucleotide position 599, causing the glycine (G) at amino acid position 200 to be replaced by a glutamic acid (E). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at